Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Shapiro

Showing results (1041-1050 of 1,181) with videos related to

Pageof 119
Sort By:
Cancer|August 27, 2014
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patientsNathaniel H Fleming, Judy Zhong, Inês Pires da Silva, et al.
The Journal of Trauma|February 16, 2010
Blunt cerebrovascular injury practice management guidelines: the Eastern Association for the Surgery of TraumaWilliam J Bromberg, Bryan C Collier, Larry N Diebel, et al.
Oncology|June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survivalTing J Tu, Michelle W Ma, Stefano Monni, et al.
Journal of the American Medical Informatics Association : JAMIA|November 6, 2021
Recruitment in a research study via chatbot versus telephone outreach: a randomized trial at a minority-serving institutionYoo Jin Kim, Julie A DeLisa, Yu-Che Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
The Journal of Infectious Diseases|December 19, 2008
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in BotswanaRoger L Shapiro, Laura Smeaton, Shahin Lockman, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Journal of Oncology Practice|August 18, 2016
Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance StatementKathleen E Bickel, Kristen McNiff, Mary K Buss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313)Hannah M Linden, Charles M Haskell, Stephanie J Green, et al.
Journal of the International AIDS Society|November 10, 2017
Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, BotswanaKathleen M Powis, Sajini Souda, Shahin Lockman, et al.
Pageof 119

Showing results (1041-1050 of 1,181) with videos related to

Sort By:
Pageof 119
Cancer|August 27, 2014
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patientsNathaniel H Fleming, Judy Zhong, Inês Pires da Silva, et al.
The Journal of Trauma|February 16, 2010
Blunt cerebrovascular injury practice management guidelines: the Eastern Association for the Surgery of TraumaWilliam J Bromberg, Bryan C Collier, Larry N Diebel, et al.
Oncology|June 25, 2011
A high proliferative index of recurrent melanoma is associated with worse survivalTing J Tu, Michelle W Ma, Stefano Monni, et al.
Journal of the American Medical Informatics Association : JAMIA|November 6, 2021
Recruitment in a research study via chatbot versus telephone outreach: a randomized trial at a minority-serving institutionYoo Jin Kim, Julie A DeLisa, Yu-Che Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
The Journal of Infectious Diseases|December 19, 2008
Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in BotswanaRoger L Shapiro, Laura Smeaton, Shahin Lockman, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Journal of Oncology Practice|August 18, 2016
Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance StatementKathleen E Bickel, Kristen McNiff, Mary K Buss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313)Hannah M Linden, Charles M Haskell, Stephanie J Green, et al.
Journal of the International AIDS Society|November 10, 2017
Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, BotswanaKathleen M Powis, Sajini Souda, Shahin Lockman, et al.
Pageof 119